StockData
Merck & Co., Inc. logo

Merck & Co., Inc.

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30250% above fair value
$149.52+3.19 (+2.18%)

Close on Oct 30, 2026Market cap $368.89BP/E 119.6Yield 2.19%

Merck Other Revenues — U.S. by Quarter

Other Revenues — U.S. ($M) ($M)

QuarterlyAnnual

Merck Other Revenues — U.S.: $5M in Q2 2026, down 44.4% from a year earlier.

Latest, Q2 2026
5
Period ended Jun 30, 2026
Change on a year earlier
-44.4%
9 in Q2 2025
History
38 quarters
Since Q4 2016
Sources
30
Documents cited below

Where the Q2 2026 figure comes from

“|| Other Revenues (8) | 72 | 110 | -35 | 5 | 9 | -44 | 67 | 100 | -33”

Source: Form 8-K (tm2621496d1_ex99-1.htm, filed 2026-08-04) ↗

Reported in Form 8-K Table 3a / 3b.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOther Revenues — U.S. ($M) ($M)Year on yearSource
Q2 2026Jun 30, 20265-44.4%Form 8-K (tm2621496d1_ex99-1.htm, filed 2026-08-04) ↗
Q4 2025Dec 31, 202529+81.3%Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗
Q3 2025Sep 30, 202515-31.8%Form 8-K (tm2529620d1_ex99-1.htm, filed 2025-10-30) ↗
Q2 2025Jun 30, 20259-59.1%Form 8-K (tm2621496d1_ex99-1.htm, filed 2026-08-04) ↗
Q1 2025Mar 31, 202593+36.8%Form 8-K (tm2512885d1_ex99-1.htm, filed 2025-04-24) ↗
Q4 2024Dec 31, 202416+433.3%Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗
Q3 2024Sep 30, 202422-78.0%Form 8-K (tm2529620d1_ex99-1.htm, filed 2025-10-30) ↗
Q2 2024Jun 30, 202422-181.5%Form 8-K (tm2521736d1_ex99-1.htm, filed 2025-07-29) ↗
Q1 2024Mar 31, 202468+13.3%Form 8-K (tm2512885d1_ex99-1.htm, filed 2025-04-24) ↗
Q4 2023Dec 31, 20233-75.0%Form 8-K (tm255059d1_ex99-1.htm, filed 2025-02-04) ↗
Q3 2023Sep 30, 2023100-55.9%Form 8-K (tm2426878d1_ex99-1.htm, filed 2024-10-31) ↗
Q2 2023Jun 30, 2023-27-177.1%Form 8-K (tm2420272d1_ex99-1.htm, filed 2024-07-30) ↗
Q1 2023Mar 31, 202360-35.5%Form 8-K (tm2412490d1_ex99-1.htm, filed 2024-04-25) ↗
Q4 2022Dec 31, 202212-83.8%Form 8-K (tm244517d1_ex99-1.htm, filed 2024-02-01) ↗
Q3 2022Sep 30, 2022227+63.3%Form 8-K (tm2328962d1_ex99-1.htm, filed 2023-10-26) ↗
Q2 2022Jun 30, 202235-683.3%Form 8-K (tm2322190d1_ex99-1.htm, filed 2023-08-01) ↗

Cite this data

StockData. (2026). Merck Other Revenues — U.S. ($M), quarterly Q4 2016–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/rev-other-revenues-us

See every metric in the Merck KPI table. Data updated Oct 26, 2026.